The Technical Analyst
Neovasc Inc [NVCN]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
Neovasc Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $30.03
America/New_York / 10 apr 2023 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 82.86 mill |
| EPS: | -15.07 |
| P/E: | -1.993 |
| Earnings Date: | Aug 09, 2023 |
| SharesOutstanding: | 2.76 mill |
| Avg Daily Volume: | 0.0258 mill |
| RATING 2023-04-20 |
|---|
| B+ |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Neutral | |
| Return On Asset: | Neutral | |
| DE: | Sell | |
| P/E: | Buy | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/21 | 1/22 | 2/22 | 3/22 | 4/22 | 2/23 | |
| Revenue | n/a | |||||
| Gr.Profit | n/a | |||||
| Ebit | n/a | |||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -1.993 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.01x |
| Company: PE -1.993 | industry: PE 222.16 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 29.59 - 30.47 ( +/- 1.45%) |
| ATR Model: 14 days |
Forecast:
01:40 - $35.60
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $30.03 (0.00% ) |
| Volume | 0.0000 mill |
| Avg. Vol. | 0.0258 mill |
| % of Avg. Vol | 0.0039 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For NVCN
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
NVCN
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.
Latest Press Releases
2023-04-11 08:20:00 - Press Release
Shockwave Medical, Inc. Completes Acquisition Of Neovasc
Santa clara, ca, april 11, 2023 (globe newswire) -- via newmediawire – shockwave medical, inc. (nasdaq: swav) (“shockwave”), a pioneer in the development of intravascular lithotripsy (ivl) to treat severely calcified cardiovascular disease, today announced the completion of its previously announced acquisition of neovasc inc. (“neovasc”).
2023-04-11 07:59:00 - Press Release
Shockwave Medical Completes Acquisition Of Neovasc
Santa clara, calif., april 11, 2023 (globe newswire) -- shockwave medical, inc. (nasdaq: swav) (“shockwave”), a pioneer in the development of intravascular lithotripsy (“ivl”) to treat severely calcified cardiovascular disease, today announced the completion of its previously announced acquisition of neovasc inc. (“neovasc”).
2023-03-31 16:11:00 - Press Release
Neovasc Announces Fourth Quarter And Fiscal Year 2022 Financial Results And Provides Corporate Update
Vancouver and minneapolis, mn, march 31, 2023 (globe newswire) -- via newmediawire – neovasc inc. (“neovasc” or the “company”) (nasdaq, tsx: nvcn) today reported financial results for the fourth quarter and year ended december 31, 2022.
2023-03-06 18:00:00 - Press Release
Neovasc Shareholders Approve Acquisition By Shockwave Medical
Vancouver, british columbia--(newsfile corp. - march 6, 2023) - neovasc inc. (nasdaq: nvcn) (tsx: nvcn) ("neovasc" or the "company"), a leader in the development of minimally invasive devices for the treatment of refractory angina, is pleased to announce that its shareholders (as defined below) have approved the previously-announced acquisition of all of the outstanding common shares of the company (the "shares") by shockwave medical, inc. ("shockwave") by way of a statutory plan of arrangement (the "arrangement") at the special meeting of shareholders held today (the "meeting"). the special resolution approving the arrangement was approved by: (i) 97.36% of the votes cast by the shareholders of the company (the "shareholders") present in person or represented by proxy at the meeting, and (ii) 97...
2023-02-01 09:05:00 - Press Release
Neovasc Announces German Reimbursement Renewal
Vancouver, british columbia and minneapolis, minnesota--(newsfile corp. - february 1, 2023) - neovasc, inc. (nasdaq : nvcn) (tsx : nvcn) ("neovasc" or "the company") today announced the german institute for the hospital remuneration system ("inek") has awarded the neovasc reducer™ ("reducer"), a ce-marked medical device for the treatment of refractory angina, nub status 1 designation for 2023.
Latest News
2023-02-22 05:39:00 - The Motley Fool
A Bull Market Is Coming: 1 Outstanding Growth Stock Down 36% to Buy and Hold
This up-and-coming medical technology star is set up to deliver market-beating gains for its long-term investors.
2023-01-27 08:17:09 - MarketBeat
Mergers and Acquisitions in 2023 Off To A Strong Start
Mergers and acquisitions are a normal part of business, but 2023 has already presented many opportunities across the biotech industry. The M&A surge seems to be driven by two major transactions: the $6 billion sale of LHC Group Inc. (Nasdaq: LHCG) to UnitedHealth (NYSE: UNH) and the $8 billion sale of Signify Health Inc. (NYSE: SGFY) to CVS Health Co. (NYSE: CVS).
2023-01-18 09:33:14 - Pulse2
Shockwave Medical To Buy Neovasc: Details (NVCN)
2023-01-11 10:32:36 - Zacks Investment Research
Neovasc (NVCN) is on the Move, Here's Why the Trend Could be Sustainable
Neovasc (NVCN) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
2022-12-26 10:32:25 - Zacks Investment Research
Recent Price Trend in Neovasc (NVCN) is Your Friend, Here's Why
Neovasc (NVCN) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
2022-11-10 21:49:07 - Zacks Investment Research
Neovasc (NVCN) Reports Q3 Loss, Misses Revenue Estimates
Neovasc (NVCN) delivered earnings and revenue surprises of -6.38% and 7.70%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
2022-11-10 20:03:03 - Seeking Alpha
Neovasc Inc. (NVCN) Q3 2022 Earnings Call Transcript
Neovasc Inc. (NASDAQ:NVCN ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Mike Cavanaugh - Investor Relations Fred Colen - President & Chief Executive Officer Chris Clark - Chief Financial Officer Conference Call Participants David Martin - Bloom Burton Operator Good day, and welcome to the Neovasc Incorporated Third Quarter Earnings Call. At this time, I will turn the call over to Mark Cavanaugh.
2022-08-30 09:05:00 - GlobeNewsWire
Neovasc to Participate in H.C. Wainwright 24th Annual Global Investment Conference
VANCOUVER and MINNEAPOLIS, Aug. 30, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc, Inc. (Neovasc or the Company) ( NASDAQ , TSX : NVCN) today announced that its management team will be participating in the H.C. Wainwright 24th Annual Global Investment Conference to be held September 12-14, 2022, in New York City. Neovasc's President and Chief Executive Officer, Fred Colen, will be presenting at 1:30 pm ET on Tuesday, September 13, 2022.
2022-08-11 20:34:07 - Seeking Alpha
Neovasc Inc. (NVCN) CEO Fred Colen on Q2 2022 Results - Earnings Call Transcript
Neovasc Inc. (NASDAQ:NVCN ) Q2 2022 Results Conference Call August 11, 2022 4:30 PM ET Company Participants Mike Cavanaugh - Investor Relations Fred Colen - President and Chief Executive Officer Chris Clark - Chief Financial Officer Conference Call Participants Vernon Bernardino - H. C. Wainwright Operator Greetings and welcome to Neovasc Inc Second Quarter 2022 Earnings Call.
2022-06-08 09:05:00 - Newsfile Corp
Neovasc to Participate in Sidoti & Co. Summer Small Cap Virtual Investor Conference
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - June 8, 2022) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) (Neovasc or the Company) today announced that its management team will be participating in the 2022 Sidoti & Co. Summer Small Cap Virtual Investor Conference to be held June 15-16, 2022. Neovasc's Chief Operating Officer, Bill Little, will be presenting at 1:45 pm ET on Wednesday, June 15.The presentation can be accessed here. Additionally, a recording of the...